Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Biol Med ; 104: 20-31, 2017 03.
Article in English | MEDLINE | ID: mdl-28069522

ABSTRACT

Recent studies reveal 2-aminoadipic acid (2-AAA) is both elevated in subjects at risk for diabetes and mechanistically linked to glucose homeostasis. Prior studies also suggest enrichment of protein-bound 2-AAA as an oxidative post-translational modification of lysyl residues in tissues associated with degenerative diseases of aging. While in vitro studies suggest redox active transition metals or myeloperoxidase (MPO) generated hypochlorous acid (HOCl) may produce protein-bound 2-AAA, the mechanism(s) responsible for generation of 2-AAA during inflammatory diseases are unknown. In initial studies we observed that traditional acid- or base-catalyzed protein hydrolysis methods previously employed to measure tissue 2-AAA can artificially generate protein-bound 2-AAA from an alternative potential lysine oxidative product, lysine nitrile (LysCN). Using a validated protease-based digestion method coupled with stable isotope dilution LC/MS/MS, we now report protein bound 2-AAA and LysCN are both formed by hypochlorous acid (HOCl) and the MPO/H2O2/Cl- system of leukocytes. At low molar ratio of oxidant to target protein Nε-lysine moiety, 2-AAA is formed via an initial Nε-monochloramine intermediate, which ultimately produces the more stable 2-AAA end-product via sequential generation of transient imine and semialdehyde intermediates. At higher oxidant to target protein Nε-lysine amine ratios, protein-bound LysCN is formed via initial generation of a lysine Nε-dichloramine intermediate. In studies employing MPO knockout mice and an acute inflammation model, we show that both free and protein-bound 2-AAA, and in lower yield, protein-bound LysCN, are formed by MPO in vivo during inflammation. Finally, both 2-AAA and to lesser extent LysCN are shown to be enriched in human aortic atherosclerotic plaque, a tissue known to harbor multiple MPO-catalyzed protein oxidation products. Collectively, these results show that MPO-mediated oxidation of protein lysyl residues serves as a mechanism for producing 2-AAA and LysCN in vivo. These studies further support involvement of MPO-catalyzed oxidative processes in both the development of atherosclerosis and diabetes risk.


Subject(s)
2-Aminoadipic Acid/metabolism , Inflammation/metabolism , Oxidative Stress/genetics , Peroxidase/genetics , Proteins/metabolism , Animals , Atherosclerosis/metabolism , Atherosclerosis/pathology , Diabetes Mellitus/metabolism , Diabetes Mellitus/pathology , Humans , Hydrogen Peroxide/metabolism , Hypochlorous Acid/metabolism , Inflammation/pathology , Leukocytes/metabolism , Leukocytes/pathology , Lysine/metabolism , Mice , Mice, Knockout , Nitriles/metabolism , Oxidation-Reduction , Peroxidase/metabolism , Protein Binding , Protein Processing, Post-Translational/genetics , Risk Factors , Tandem Mass Spectrometry
2.
Elife ; 42015 Apr 07.
Article in English | MEDLINE | ID: mdl-25846707

ABSTRACT

Aging is a multifactorial process that includes the lifelong accumulation of molecular damage, leading to age-related frailty, disability and disease, and eventually death. In this study, we report evidence of a significant correlation between the number of genes encoding the immunomodulatory CD33-related sialic acid-binding immunoglobulin-like receptors (CD33rSiglecs) and maximum lifespan in mammals. In keeping with this, we show that mice lacking Siglec-E, the main member of the CD33rSiglec family, exhibit reduced survival. Removal of Siglec-E causes the development of exaggerated signs of aging at the molecular, structural, and cognitive level. We found that accelerated aging was related both to an unbalanced ROS metabolism, and to a secondary impairment in detoxification of reactive molecules, ultimately leading to increased damage to cellular DNA, proteins, and lipids. Taken together, our data suggest that CD33rSiglecs co-evolved in mammals to achieve a better management of oxidative stress during inflammation, which in turn reduces molecular damage and extends lifespan.


Subject(s)
Longevity , Mammals/physiology , Oxidative Stress , Receptors, Cell Surface/metabolism , Animals , Body Weight , Homeostasis , Immunomodulation , Male , Mammals/genetics , Mice, Inbred C57BL , Multigene Family , Phenotype , Phylogeny , Reactive Oxygen Species/metabolism , Sialic Acid Binding Immunoglobulin-like Lectins/deficiency , Sialic Acid Binding Immunoglobulin-like Lectins/metabolism
3.
Biomaterials ; 35(7): 2097-102, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24360721

ABSTRACT

The clinical use of bioprosthetic heart valves (BHV) is limited due to device failure caused by structural degeneration of BHV leaflets. In this study we investigated the hypothesis that oxidative stress contributes to this process. Fifteen clinical BHV that had been removed for device failure were analyzed for oxidized amino acids using mass spectrometry. Significantly increased levels of ortho-tyrosine, meta-tyrosine and dityrosine were present in clinical BHV explants as compared to the non-implanted BHV material glutaraldehyde treated bovine pericardium (BP). BP was exposed in vitro to oxidizing conditions (FeSO4/H2O2) to assess the effects of oxidation on structural degeneration. Exposure to oxidizing conditions resulted in significant collagen deterioration, loss of glutaraldehyde cross-links, and increased susceptibility to collagenase degradation. BP modified through covalent attachment of the oxidant scavenger 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine (DBP) was resistant to all of the monitored parameters of structural damage induced by oxidation. These results indicate that oxidative stress, particularly via hydroxyl radical and tyrosyl radical mediated pathways, may be involved in the structural degeneration of BHV, and that this mechanism may be attenuated through local delivery of antioxidants such as DBP.


Subject(s)
Bioprosthesis , Heart Valve Prosthesis , Adult , Aged , Aged, 80 and over , Animals , Cattle , Female , Humans , Male , Middle Aged , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL
...